首页|Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis

Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis

扫码查看
Fulminant myocarditis is an acute diffuse inflammatory disease of myocardium.It is characterized by acute onset,rapid progress and high risk of death.Its pathogenesis involves excessive immune activation of the innate immune system and formation of inflammatory storm.According to China's practical experience,the adoption of the"life support-based comprehensive treatment regimen"(with mechanical circulation support and immunomodulation therapy as the core)can significantly improve the survival rate and long-term prognosis.Special emphasis is placed on very early identification,very early diagnosis,very early prediction and very early treatment.

fulminant myocarditisguidelineslife support-based comprehensive treatment regimendiagnosistreatmentcytokine stormoveractivation of immunity

Chinese Society of Cardiology,Chinese Medical Association,Writing Group、Jiangang Jiang、Hongyang Shu、Dao Wen Wang、Rutai Hui、Chenze Li、Xiao Ran、Hong Wang、Jing Zhang、Shaoping Nie、Guanglin Cui、Dingcheng Xiang、Qun Shao、Shengyong Xu、Ning Zhou、Yuming Li、Wei Gao、Yuguo Chen、Yuan Bian、Guoping Wang、Liming Xia、Yan Wang、Chunxia Zhao、Zhiren Zhang、Yuhua Zhao、Jianan Wang、Shaoliang Chen、Hong Jiang、Jing Chen、Xianjin Du、Mao Chen、Yinxian Sun、Sheng Li、Hu Ding、Xueping Ma、Hesong Zeng、Li Lin、Shenghua Zhou、Likun Ma、Ling Tao、Juan Chen、Yiwu Zhou、Xiaomei Guo

展开 >

Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China

Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China

Zhongnan Hospital of Wuhan University,Wuhan 430062,China

Fuwai Huazhong Cardiovascular Hospital,Zhengzhou 450003,China

Beijing Anzhen Hospital,Capital Medical University, Beijing 100029, China

Guangzhou General Hospital of Guangzhou Military Command,Guangzhou 510010,China

Harbin Medical University Cancer Hospital,Harbin 150081,China

Union Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China

Taida Hospital,Tianjin 300457,China

Peking University Third Hospital,Beijing 100191,China

Qilu Hospital of Shandong University,Ji'nan 250012,China

Kanghua Hospital,Dongguan,Guangzhou 523080,China

Second Affiliated Hospital Zhejiang University School of Medicine,Hangzhou 310003,China

Nanjing First Hospital,Nanjing Medical University,Nanjing 210006,China

Renmin Hospital of Wuhan University,Wuhan 430060,Wuhan

West China Hospital,Sichuan University,Chengdu 610044,China

First Hospital of China Medical University,Shenyang 110002,China

General Hospital of Ningxia Medical University,Yinchuan 750003,China

The Second Xiangya Hospital,Central South University,Changsha 410012,China

The First Affiliated Hospital of USTC,University of Science and Technology of China,Hefei 230002,China

the First Affiliated Hospital of Air Force Medical University,Xi'an 710032,China

Central Hospital of Wuhan City,Wuhan 430014,China

Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China

展开 >

National Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaTop-Notch Talent Program of Hubei Province and Tongji Hospital

81790624816300102021YBJRC005

2024

中国科学:生命科学(英文版)
中国科学院

中国科学:生命科学(英文版)

CSTPCD
影响因子:0.806
ISSN:1674-7305
年,卷(期):2024.67(5)